SEC Contract Filing

Filing Date: 2020-05-11

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>mylex10120200331-10q.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
 <!-- Document created using Wdesk 1 -->
 <!-- Copyright 2020 Workiva -->
 <title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sDDC69CC6185EE4C96E40E13D8F30DA07"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit 10.1</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">MYLAN N.V.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">2003 LONG-TERM INCENTIVE PLAN</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">NOTICE OF AWARD OF RESTRICTED STOCK UNITS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">[ ]</font><font style="font-family:inherit;font-size:12pt;">&#32;(the &#8220;Participant&#8221;) has been granted, effective as of the grant date </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">[ ]</font><font style="font-family:inherit;font-size:12pt;">, an award of restricted stock units (the &#8220;Award&#8221;) payable in ordinary shares (the &#8220;Shares&#8221;) of Mylan N.V. (the &#8220;Company&#8221;) pursuant to the Company&#8217;s 2003 Long-Term Incentive Plan, as amended to date (the &#8220;Plan&#8221;), in respect of the Participant&#8217;s service as a member of the Board. The Award is subject to the terms and conditions set forth below and in the Plan, which is a part of this Notice (this &#8220;Award Agreement&#8221;).</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:left;text-indent:96px;"><font style="padding-bottom:16px;text-align:left;font-family:inherit;font-size:12pt;font-weight:bold;padding-right:96px;">1.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Number of Restricted Stock Units (RSUs):</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">[ ]</font><font style="font-family:inherit;font-size:12pt;">, where 1 RSU is equal to the right to receive 1 Share.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Vesting:</font><font style="font-family:inherit;font-size:12pt;">&#32;Restrictions on the RSUs lapse (and shares will be released to the Participant) on the first anniversary of the grant date (the &#8220;Vesting Date&#8221;), subject to the Participant&#8217;s continued service as a member of the Board as of the Vesting Date and the terms of the Plan and this Award Agreement. Subject to Section 3, unless otherwise determined by the Board or the Committee, as applicable, in its sole discretion, in the event the Participant&#8217;s service as a member of the Board terminates prior to the Vesting Date, the RSUs shall be forfeited and returned to the Company, and all rights of the Participant with respect to the RSUs shall terminate, as of the date of such termination of service. For purposes of this Award Agreement, service as a member of the board of directors of the ultimate parent company of the Company shall be deemed to be service as a member of the Board. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Change in Control</font><font style="font-family:inherit;font-size:12pt;">: Notwithstanding anything to the contrary in the Plan, in the event of a Change in Control, the treatment of the RSUs shall be determined by the Board or the Committee, as applicable, in its sole discretion; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that, in connection with the consummation of the transactions contemplated by the Business Combination Agreement between the Company, Pfizer Inc., Upjohn Inc. and the other parties thereto, dated as of July 29, 2019 (the &#8220;BCA&#8221;, and such transactions, the &#8220;Proposed Combination&#8221;), the RSUs shall be subject to the terms of the BCA, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">&#32;that, in the event that immediately following the consummation of the Proposed Combination the Participant does not serve as a member of the board of directors of Viatris, all restrictions on the RSUs shall lapse (and shares will be released to the Participant) as of immediately prior to the consummation of the Proposed Combination.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">4.</font><font style="font-f